Introduction
Lutembacher syndrome, first described by Lutembacher in 1916 , is a combination of a congenital atrial septal defect (ASD) and acquired mitral stenosis (MS) 1 . Mitral stenosis serves to augment the left-to-right atrial shunt through the ASD, but decompression of the obstructed left atrium by the ASD attenuates the symptoms of MS 2 .
The condition is usually treated surgically 3 , however, both abnormalities are amenable to percutaneous transcatheter therapy [4] [5] [6] [7] [8] . Inter-atrial septum develops from two sources-septum primium and septum secundum. If there is defect in the formation of septum primium, it forms ASD (Primium) and If the defect is in the formation of septum secundum it forms ASD (secundum). Mitral stenosis is an acquired heart disease develops due to recurrent attack of Rheumatic carditis. So, for the development of Lutembacher's syndrome defect in the formation of septum secundum and recurrent Rheumatic carditis are required.
It is very rare. It is found that the incidence of Lutembacher's syndrome is-0.001/10,00000. The incidence of MS in patients with ASD is 4% and conversely, the incidence of ASD in patients with MS is 0.6-0.7% (10) . It occurs predominantly in women. It usually presents in young adults but may present in elderly patients.
She has history of repeated attack of fever in childhood. On examination in our hospital, pulse was 70 beats/min, irregularly irregular and of small volume. BP -100/60 mm of Hg, Jugular Venous Pressure (JVP) was raised, no ankle oedema. Precordial examination revealed accentuation of the first heart sound with an opening snap and a grade 3/6 mid-to-late diastolic rumbling murmur at the apex. Additionally, there were features suggestive of ASD, such as fixed splitting of the second heart sound with a grade 3/6 ejection systolic murmur at the pulmonary area. 
Follow-up
6 months after operation postoperative follow-up with Echocardiographic evaluation was carried out. Transthoracic echocardiography showed intact patch in situ with no intracardiac residual shunt. The mitral valve area was 2.3 cm 2 by planimetry and Doppler methods.
There was trivial mitral regurgitation. Both AML & PML were minimally thickened, both commissures were partially fused. Mild calcification present in both leaflets. Mild subvalvular changes were noted.
Post oparative echocardiogram at 6 month
Discussion
The original case describing Lutembacher syndrome involved a 61-year-old woman who had been pregnant 7 times 1 . Female predominance has been noted in both ASD and MS, and thus Lutembacher syndrome has a predilection for females. The incidence of MS in patients with ASD is 4% and conversely, the incidence of ASD in patients with MS is 0.6-0.7% 10 . In
Lutembacher syndrome, MS augments the left-to right shunt through the ASD, while the non-restrictive ASD decompresses the left atrium, reducing the diastolic mitral pressure gradient 11 . Planimetry and the Doppler continuity equation methods yield an accurate mitral valve area in the Lutembacher syndrome 12, 13 . The experience with transcatheter treatment of the Lutembacher syndrome is small 2,3,9, 14-17 .
In Lutembacher's syndrome, initially, high left atrial pressure due to mitral stenosis was thought to stretch open the patent foramen ovale, causing left-to-right shunt and providing another outlet for the left atrium. Now ASD in this syndrome, like mitral stenosis, is recognized as being either congenital or acquired, as already described. The haemodynamic effects of this syndrome are a result of the interplay between the relative effects of ASD and mitral stenosis. In its initial description, the ASD was typically large in Lutembacher syndrome, thus providing another route for blood flow. The direction of blood flow is determined largely by the compliance of left and right ventricles. Normally, the right ventricle is more compliant than the left ventricle. As a result, in the presence of mitral stenosis, blood flows to the right atrium through the ASD instead of going backward into the pulmonary veins, thus avoiding pulmonary congestion. This happens at the cost of progressive dilatation and, ultimately, failure of the right ventricle and reduced blood flow to the left ventricle. Development of Eisenmenger syndrome or irreversible pulmonary vascular disease is very uncommon in the presence of large ASD and high left atrial pressure because of mitral stenosis.
The ameliorating role of the ASD in MS was evident in Lutembacher's original report of 1916; the patient was a 61-year-old woman who had been pregnant seven times 1 . An earlier case report in the literature in 1880
(and referred to by Perloff) was of a 74-year-old woman who had endured 11 pregnancies 10 . Survival to advanced age has also been reported 12 . In one instance an 81-yearold woman experienced no symptoms related to her heart disease until she reached 75 years of age 12 .
These favourable reports, however, should not obscure the fact that the long-term natural history of ASD is unfavourably influenced by MS, which augments the left-to-right shunt and predisposes to atrial fibrillation and right ventricular failure 13 . The presence of MS, especially when accompanied by mitral regurgitation, increases susceptibility to infective endocarditis, in contrast to the low incidence of infective endocarditis in uncomplicated ASD, 10 just like in our case.
In Bangladesh, a case of Lutembacher syndrome involving inoperable elderly patient was reported from Faridpur medical college hospital 18 . Early diagnosis and surgical treatment bears a good prognostic value. If patient is diagnosed at late stage, pulmonary hypertension and heart failure develops and the prognosis is bad 14 . If the patient is diagnosed earlier before the development of pulmonary hypertension and heart failure, -ASD closure with mitral valve replacement bears a good prognosis and prolongs survival of the patient.
Summary and Conclusion
Lutembacher's syndrome is a rare, complex, congenital heart disease. Early diagnosis and operative treatment has a good prognostic value but late diagnosis and development of heart failure bears bad prognosis. Most of the patients die subsequently due to heart failure, cardiac arrhythmias and thrombo-embolic cerebrovascular diseases. Early diagnosis and management can reduce morbidity and mortality.
